Research Paper Volume 15, Issue 15 pp 7655—7672
Development of anoikis-related long non-coding RNA signature associated with prognosis and immune landscape in cutaneous melanoma patients
Figure 9. Immunophenoscore (IPS) and immune scores of patients in the low- and high-risk group. (A, B) IPS shows the immunotherapy reaction of CM patients in the low- and high-risk group. (C) TIDE score. (D) immune function score. (E) The expression of immune checkpoint inhibitors (ICI) in the low- and high-risk group. The expression is transformed by log2(expression + 1).